When skin is broken, platelets rush to the wound site and stick together, then trigger a cascade of chemical reactions that convert soluble fibrinogen into insoluble fibrin. Fibrin fibres form a mesh that traps red blood cells, creating a clot that seals the wound and prevents blood loss and infection.
What is blood clotting and why is it essential?
Blood clotting (haemostasis) is the process by which the body seals a damaged blood vessel to stop bleeding. Without it, even a small cut could lead to uncontrolled blood loss.
Clotting also forms a physical barrier that prevents bacteria from entering through the wound. Once the clot dries, it becomes a scab, under which new skin cells divide and replace the damaged tissue.
Blood contains three components that work together in clotting:
- Platelets — tiny cell fragments (no nucleus) produced by the fragmentation of large bone-marrow cells called megakaryocytes
- Clotting factors — proteins dissolved in the plasma that form a cascade of reactions
- Fibrinogen — a soluble plasma protein that becomes insoluble fibrin during clotting
What role do platelets play at the wound site?
When a blood vessel wall is damaged, it exposes collagen fibres beneath the endothelium. Platelets have surface receptors that detect exposed collagen and respond immediately:
- Platelets become activated — they change shape from smooth discs to spiky spheres with extended projections.
- Activated platelets become sticky and adhere to the collagen and to each other.
- They aggregate rapidly, forming a loose platelet plug that physically blocks the gap.
- Activated platelets also release chemical signals that attract more platelets and trigger the clotting cascade.
The platelet plug forms within seconds and gives an immediate but fragile seal. The clotting cascade then reinforces it with fibrin.
How does the clotting cascade produce fibrin?
The clotting cascade is a series of enzyme reactions, each activating the next:
| Step | Event |
|---|---|
| 1 | Damaged tissue and activated platelets release thromboplastin (tissue factor) |
| 2 | Thromboplastin converts inactive prothrombin → active thrombin (requires Ca²⁺ ions and vitamin K) |
| 3 | Thrombin (an enzyme) converts soluble fibrinogen → insoluble fibrin |
| 4 | Fibrin forms long, sticky strands that create a mesh over the platelet plug |
| 5 | Red blood cells and more platelets are trapped in the mesh → the clot forms |
| 6 | The clot contracts and hardens → a scab forms on the surface |
The cascade is amplified at each step — a tiny initial signal produces a large amount of fibrin. Calcium ions (Ca²⁺) and vitamin K are essential cofactors; without adequate vitamin K, the cascade cannot proceed properly.
What happens when blood clotting goes wrong?
Clotting is highly regulated, and both too little and too much clotting are dangerous:
Too little clotting:
- Haemophilia A: a genetic disorder (X-linked recessive) caused by a deficiency of clotting factor VIII. Even minor injuries cause prolonged bleeding; internal bleeding into joints is common. Treated by injecting purified factor VIII.
- Haemophilia B (Christmas disease): deficiency of clotting factor IX; similar symptoms.
- Vitamin K deficiency: reduced production of several clotting factors.
Too much clotting (thrombosis):
- Deep vein thrombosis (DVT): a clot forms inside a vein (usually in the leg) without injury. Can travel to the lungs (pulmonary embolism) or brain (stroke) with fatal consequences.
- Coronary thrombosis: clot blocks a coronary artery → heart attack.
- Risk factors: inactivity, dehydration, obesity, smoking, and certain medications.
Anticoagulant drugs such as warfarin and heparin reduce clotting risk in high-risk patients by interfering with clotting factors or thrombin.
What factors are needed for successful clotting?
For normal clotting to occur, the body needs:
- An adequate number of functioning platelets
- All the essential clotting factors (at least 13 are known)
- Sufficient calcium ions (Ca²⁺) — always present in normal blood
- Adequate vitamin K (needed for synthesis of factors II, VII, IX, X in the liver)
- An intact liver — most clotting factors are synthesised there
Patients with liver disease often have clotting problems because the liver cannot produce enough clotting factors.
Frequently asked questions
What is the difference between fibrinogen and fibrin?
Fibrinogen is a large, soluble protein that circulates dissolved in the plasma under normal conditions. It does not form clots on its own. When thrombin (an enzyme activated during the clotting cascade) acts on fibrinogen, it cleaves small peptide fragments from the molecule. The remaining fibrin monomers then spontaneously polymerise, forming long, insoluble fibrin strands that mesh together to create the structural framework of the blood clot. The key difference is solubility: fibrinogen is soluble, fibrin is insoluble.
Why do platelets need to be activated before they stick together?
Resting platelets circulate without sticking to each other or to vessel walls — if they stuck spontaneously, clots would form everywhere and block healthy vessels. Activation is triggered by specific signals: exposure of collagen (only accessible when a vessel is damaged), thrombin produced in the cascade, and chemical signals released by other activated platelets. Only when these signals are present do platelets change shape and express surface proteins (such as glycoprotein IIb/IIIa) that allow binding. This system ensures clotting happens only at the site of injury.
How does haemophilia A differ from haemophilia B?
Both conditions result in prolonged bleeding because the clotting cascade cannot proceed normally. Haemophilia A (the more common form, affecting about 1 in 5,000 males) is caused by a deficiency or absence of clotting factor VIII. Haemophilia B is caused by a deficiency of clotting factor IX. Both are X-linked recessive — they mainly affect males (who have only one X chromosome) and are carried by females. Both are treated by regular infusion of the missing clotting factor, now largely produced by recombinant DNA technology.
What is the role of vitamin K in blood clotting?
Vitamin K is a fat-soluble vitamin that acts as an essential cofactor for an enzyme in the liver that chemically modifies certain clotting proteins (factors II, VII, IX, and X) in a way that allows them to function in the cascade. Without this modification, these proteins cannot bind calcium ions properly and are non-functional. This is why vitamin K deficiency — which can occur in newborns (who receive a preventative injection) or in patients on broad-spectrum antibiotics that kill vitamin K–producing gut bacteria — causes a bleeding tendency. The anticoagulant drug warfarin works by blocking this vitamin K–dependent step.
For Socratic GCSE biology with Professor Darwin — following the clotting cascade from platelet to fibrin mesh to healed tissue — visit aitutors.me.